From: Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease
CD4 cell count | Item | Period | Average 1–24 months per patient | ||||
---|---|---|---|---|---|---|---|
Before ART | 1–6 months | 7–12 months | 13–18 months | 19–24 months | |||
0–50 | Number of patients | 96 | 96 | 95 | 84 | 61 |  |
 | Hospitalization | 1483 (10 %) | 6161 (9 %) | - | - | - | 64 |
 | Outpatient visits | 1110 (8 %) | 6707 (10 %) | 6462 (12 %) | 5247 (11 %) | 3517 (11 %) | 258 |
 | OI treatment | 86 (1 %) | 10867 (16 %) | 2163 (4 %) | 564 (1 %) | 1538 (5 %) | 168 |
 | ARV drugs | - | 40012 (60 %) | 41281 (78 %) | 37724 (81 %) | 26915 (81 %) | 1742 |
 | CD4 test | 1254 (9 %) | 620 (1 %) | 990 (2 %) | 832 (2 %) | 541 (2 %) | 36 |
 | Viral load test | - | 396 (1 %) | 1056 (2 %) | 594 (1 %) | 264 (1 %) | 27 |
 | Routine lab test | 10452 (73 %) | 1488 (2 %) | 1289 (2 %) | 1548 (3 %) | 363 (1 %) | 53 |
 | Total costs | 14377 (100 %) | 66205 (100 %) | 53196 (100 %)c | 46472 (100 %c | 33115 (100 %)c | 2346 |
 | Average costs per patientb | 150 (139 – 160) | 690 (593–787) | 560 (521–599) | 553 (515–592) | 543 (480–606) |  |
50–100 | Number of patients | 33 | 33 | 33 | 32 | 25 |  |
 | Hospitalization | 57 (1 %) | 418 (2 %) | - | - | - | 13 |
 | Outpatient visits | 421 (9 %) | 2337 (12 %) | 2232 (11 %) | 1951 (11 %) | 1110 (11 %) | 244 |
 | OI treatment | 12 (0.3 %) | 725 (4 %) | 2099 (10 %) | 13 (0.1 %) | 9 (0.1 %) | 86 |
 | ARV drugs | - | 14694 (77 %) | 15360 (73 %) | 14763 (83 %) | 9058 (87 %) | 1734 |
 | CD4 test | 475 (10 %) | 172 (1 %) | 383 (2 %) | 264 (1 %) | 132 (1 %) | 30 |
 | Viral load test | - | 330 (2 %) | 396 (2 %) | 264 (1 %) | - | 30 |
 | Routine lab test | 3608 (79 %) | 478 (2 %) | 494 (2 %) | 508 (3 %) | 104 (1 %) | 49 |
 | Total costs | 4570 (100 %) | 19138 (100 %) | 20947 (100 %) | 17749 (100 %) | 10405 (100 %)c | 2186 |
 | Average costs per patientb | 138 (126–151) | 580 (567–593) | 635 (622–648) | 555 (542–568) | 473 (460–486) |  |
100–150 | Number of patients | 22 | 22 | 22 | 18 | 13 |  |
 | Hospitalization | - | 418 (4 %) | - | - | - | 19 |
 | Outpatient visits | 339 (10 %) | 1566 (14 %) | 1391 (13 %) | 1157 (13 %) | 771 (14 %) | 258 |
 | OI treatment | - | 815 (7 %) | 77 (0.7 %) | 29 (0.3 %) | 2 (0.04 %) | 42 |
 | ARV drugs | - | 8147 (72 %) | 8587 (79 %) | 6858 (79 %) | 4661 (83 %) | 1500 |
 | CD4 test | 383 (11 %) | 106 (1 %) | 238 (2 %) | 172 (2 %) | 92 (2 %) | 32 |
 | Viral load test | 66 (2 %) | 66 (1 %) | 264 (2 %) | 198 (2 %) | - | 26 |
 | Routine lab test | 2547 (76 %) | 222 (2 %) | 293 (3 %) | 317 (4 %) | 63 (1 %) | 46 |
 | Total costs | 3333 (100 %) | 11329 (100 %) | 10839 (100 %) | 8722 (100 %) | 5585 (100 %) | 1922 |
 | Average costs per patientb | 159 (144–173) | 515 (500–529) | 493 (478–507) | 485 (470–499) | 430 (415–444) |  |
150–200 | Number of patients | 17 | 17 | 14 | 14 | 11 |  |
 | Hospitalization | 190 (7 %) | 57 (1 %) | - | - | - | 3 |
 | Outpatient visits | 304 (11 %) | 1133 (14 %) | 982 (15 %) | 935 (14 %) | 654 (14 %) | 263 |
 | OI treatment | - | 66 (1 %) | 3 (0.05 %) | 5 (0.1 %) | - | 4 |
 | ARV drugs | - | 6188 (77 %) | 4865 (76 %) | 5162 (77 %) | 3717 (82 %) | 1418 |
 | CD4 test | 343 (12 %) | 119 (1 %) | 119 (2 %) | 145 (2 %) | 92 (2 %) | 34 |
 | Viral load test | 66 (2 %) | 264 (3 %) | 264 (4 %) | 66 (1 %) | - | 39 |
 | Routine lab test | 1969 (69 %) | 200 (2 %) | 195 (3 %) | 362 (5 %) | 63 (1 %) | 57 |
 | Total costs | 2870 (100 %) | 8020 (100 %) | 6421 (100 %) | 6670 (100 %) | 4522 (100 %) | 1818 |
 | Average costs per patientb | 169 (136–201) | 472 (445–499) | 459 (432–485) | 476 (450–503) | 411 (384–438) |  |
>200 | Number of patients | 10 | 10 | 10 | 7 | 4 | Â |
 | Hospitalization | - | - | - | - | - |  |
 | Outpatient visits | 199 (13 %) | 701 (15 %) | 608 (13 %) | 363 (12 %) | 257 (20 %) | 247 |
 | OI treatment | - | 1 (0.02 %) | - | - | - | 0.1 |
 | ARV drugs | - | 3637 (79 %) | 3797 (83 %) | 2715 (84 %) | 938 (73 %) | 1366 |
 | CD4 test | 224 (15 %) | 66 (1 %) | 79 (2 %) | 53 (2 %) | 53 (4 %) | 35 |
 | Viral load test | - | - | - | - | - |  |
 | Routine lab test | 1119 (73 %) | 223 (5 %) | 92 (2 %) | 68 (2 %) | 35 (3 %) | 50 |
 | Total costs | 1541 (100 %) | 4623 (100 %) | 4572 (100 %) | 3218 (100 %) | 1281 (100 %)c | 1699 |
 | Average costs per patientb | 154 (114–195) | 462 (437–487) | 457 (432–482) | 460 (435–485) | 320 (295–345) |  |